Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber; Judge Recommends Schedule I Placement for DOI and DOC

We returned from Psychedelic Science 2025 to a very busy week, not least due to Compass Pathways’ first Phase 3 readout (read our piece on researchers’ reactions). We’re expecting the remainder of June to be similarly eventful, so this Bulletin aims to get you up to speed with various developments across the world of psychedelics: from Washington to Auckland. *** ***

Source